Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Remme

Showing results (11-20 of 236) with videos related to

Pageof 24
Sort By:
Cardiovascular Drugs and Therapy|August 16, 2001
The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure EvaluatioN trial (CARMEN)--rationale and designW J Remme,
Journal of Cardiac Failure|December 1, 1996
Positive inotropic therapy: dead end or new horizon?W J Remme
Drugs|January 1, 1997
Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy?W J Remme
Cardiovascular Drugs and Therapy|November 18, 2003
Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapyW J Remme
Cardiovascular Drugs and Therapy|October 18, 2003
Should ACE inhibition always be first-line therapy in heart failure? Lessons from the CARMEN StudyWillem J Remme
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|December 3, 1999
How to treat diastolic heart failure: a personal point of viewW J Remme
Cardiovascular Drugs and Therapy|October 24, 2001
Dopaminergic agents in heart failure: rebirth of an old conceptW J Remme
Cardiovascular Drugs and Therapy|February 22, 2002
Positive inotropes--a new horizon or still a dead end?W J Remme
The Netherlands Journal of Medicine|October 1, 1993
Pathophysiology and therapy of heart failure, new insights and developments. Part II. Cardiac and peripheral alterations during progressive heart failureW J Remme
British Heart Journal|September 1, 1994
Inotropic agents for heart failure: what if digoxin increases mortality?W J Remme
Pageof 24

Showing results (11-20 of 236) with videos related to

Sort By:
Pageof 24
Cardiovascular Drugs and Therapy|August 16, 2001
The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure EvaluatioN trial (CARMEN)--rationale and designW J Remme,
Journal of Cardiac Failure|December 1, 1996
Positive inotropic therapy: dead end or new horizon?W J Remme
Drugs|January 1, 1997
Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy?W J Remme
Cardiovascular Drugs and Therapy|November 18, 2003
Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapyW J Remme
Cardiovascular Drugs and Therapy|October 18, 2003
Should ACE inhibition always be first-line therapy in heart failure? Lessons from the CARMEN StudyWillem J Remme
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|December 3, 1999
How to treat diastolic heart failure: a personal point of viewW J Remme
Cardiovascular Drugs and Therapy|October 24, 2001
Dopaminergic agents in heart failure: rebirth of an old conceptW J Remme
Cardiovascular Drugs and Therapy|February 22, 2002
Positive inotropes--a new horizon or still a dead end?W J Remme
The Netherlands Journal of Medicine|October 1, 1993
Pathophysiology and therapy of heart failure, new insights and developments. Part II. Cardiac and peripheral alterations during progressive heart failureW J Remme
British Heart Journal|September 1, 1994
Inotropic agents for heart failure: what if digoxin increases mortality?W J Remme
Pageof 24